FDA finalizes updates to mammography facility requirements
The Food and Drug Administration today finalized a 2019 proposed rule updating requirements under the Mammography Quality Standards Act of 1992, which authorized FDA oversight of mammography facilities. Effective Sept. 10, 2024, the rule expands the information that mammography facilities must provide to patients and health care professionals, incorporates current best practices and enhances facility oversight, the FDA said. For example, the rule requires facilities to include information on breast density in the report to the clinician and the patient’s summary letter to enable patients and their doctors to have a more informed discussion about the enhanced risks associated with dense breasts if appropriate.
Related News Articles
Headline
The Food and Drug Administration is evaluating Chinese-made plastic syringes used to inject or withdraw fluids from the body, citing concern that they may…
Headline
The latest revisions to the Centers for Medicare & Medicaid Services’ Quality Assurance and Performance Improvement program underscore the integral role of…
Headline
The Centers for Medicare & Medicaid Services yesterday released updated interpretive guidance for surveyors assessing whether a hospital’s Quality…
Headline
The Centers for Medicare & Medicaid Services Friday granted certain quality reporting exceptions to Texas acute-care hospitals, ambulatory surgical…
Headline
The blanket data reporting exceptions and extensions implemented in March across Medicare quality reporting and value-based payment programs for hospitals…
Headline
Beginning in March, the Centers for Medicare & Medicaid Services will implement a streamlined survey and certification process for psychiatric hospitals,…